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Surface immobilization of biomolecules is a key step in im-portant experimental techniques including surface plasmon
resonance (SPR) analysis1 and microarrays2 that are by now
fundamental in research areas spanning from basic sciences to
drug development. Surface functionalization with proteins is far
more complex than with DNA, mainly due to the high number of
diﬀerent functional groups and to the structural complexity of
folded proteins. Also, the need for an appropriate orientation of
the immobilized protein on the surface is crucial for receptors,
antibodies, and enzymes.3 For these immobilizations, leaving the
binding site or the catalytic pocket free can be satisﬁed only by
chemoselective methods. An ideal chemoselective protein im-
mobilization might exploit a selected functional group of the
protein and may use experimental conditions that retain protein
folding and its biological functions. Relevant to this point,
classical protein immobilization via amine or thiol groups usually
results in random conjugation without a deﬁned protein orienta-
tion. On the other hand, among the various site-speciﬁc im-
mobilization methods available, the bioorthogonal ligation
reactions, like Staudinger ligation or DielsAlder reaction, need
the introduction of a peptide tag or a non-natural amino acid that
may greatly aﬀect protein folding and activity. Lempens et al.
recently proposed oxime ligation as eﬃcient protein immobiliza-
tion strategy.4 This method requests the site-speciﬁc introduc-
tion of a ketone in the N-terminal site of the protein by oxidation
with pyridoxal-50-phosphate (PLP);5,6 the ketone is then used to
link, through an oxime bond, an oxy-amine group on the surface.
The conversion of the N-terminal group in ketone or aldehyde
can be applied to many proteins without recombinant modiﬁca-
tion with the exclusion of those containing Q, W, H, P, or K as
N-terminal residue or proteins whose N-terminus is blocked by
post-translational modiﬁcations. Oxime ligation provides a fast
and selective method for peptide and protein immobilization and
its application has been demonstrated to increase the sensitivity
of SPR analysis.7
Beside the need for chemoselective immobilization of mol-
ecules to surface/particle, equally important is the controlled
release of the immobilizedmolecules (i.e., drugs) to target tissues/
cells. This latter ﬁeld of research has direct implications in the
treatment of several important human diseases including cancer.8,9
On the basis of the above-mentioned considerations, we have
attempted the design of a bifunctional peptide linker containing
the matrix metallo proteinase (MMP)-2-cleavage site of CCL127
that could be selectively bound to a proteinketone through its
oxy-amine N-terminal group and anchored to a surface (i.e., a
gold chip) through the thiol of its C-terminal Cys (Figure 1). The
goal of this kind of strategy is twofold, probing both the possibility
to chemoseletively immobilize a protein on a surface in a deﬁned
orientation and the possibility to collect the probeligand
complex for further analyses and studies. Closely related to this
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ABSTRACT: Surface immobilization of biomolecules is a
fundamental step in several experimental techniques such as
surface plasmon resonance analysis and microarrays. Oxime
ligation allows reaching chemoselective protein immobilization
with the retention of native-like conformation by proteins.
Beside the need for chemoselective ligation of molecules to
surface/particle, equally important is the controlled release of
the immobilized molecules, even after a speciﬁc binding event.
For this purpose, we have designed and assessed in an SPR
experiment a peptide linker able to (i) anchor a given protein
(enzymes, receptors, or antibodies) to a surface in a precise orientation and (ii) release the immobilized protein after selective
enzymatic cleavage. These results open up the possibility to anchor to a surface a protein probe leaving bioactive sites free for
interaction with substrates, ligands, antigens, or drugs and successively remove the probeligand complex by enzymatic cleavage.
This peptide linker can be considered both an improvement of SPR analysis for macromolecular interaction and a novel strategy for
drug delivery and biomaterial developments.
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latter point, the study performed here opens new possibilities in
the ﬁeld of controlled release of drugs from artiﬁcial surfaces for
biomedical uses.
Figure 2 reports a schematic representation of the strategy
adopted here. In detail, a premature and uncontrolled reaction of
the highly reactive oxy-amino group of the peptide linker was
avoided by protecting it with bis-tert-butyloxycarbonyl (Bis-Boc).
The solid-phase synthesis of Bis-Boc-protected peptide linker was
possible using super acid labileMmt for Cys, 2-Cl-Trt for Tyr, and
Trt for Ser instead of acid labile side chain protections and a super
acid labile support (Sieber Amide resin). As this group is highly
reactive with aldehyde, ketones, and nitriles, acetonitrile was
avoided as eluent during HPLC puriﬁcation.The Bis-Boc-protected
peptide linker was then immobilized to a gold-coated sensorchip for
SPR analysis via thiol group of its C-terminal Cys residue. Bovine
serum albumin (BSA, here used as model protein) was PLP
oxidized, obtaining the BSA-Ketone, and the sensorchip-immo-
bilized peptide linker deprotected. Then, the chemoselective
fusion to the oxy-amine N-terminal group of the immobilized
peptide linker to BSA-Ketone was performed directly in the
ﬂuidic cell of the BIAcore apparatus (for technical details, see
Experimental Section in the Supporting Information). The
resulting sensorchip was then used to evaluate the possibility
to remove BSA from the sensorchip by injecting MMP-2.
The sensorgramof a representative experiment (out of four other
that gave similar results) is reported in Figure 3. The immobilization
of the Bis-Boc-protected peptide linker produces a RU increase of
1513 units (approximately equal to 129 pmol/cm2). The further
functionalization of the surface with BSA-Ketone through oxime
formation shows a further RU increase equal to 1165 units, that
approximately corresponds to 1.75 pmol/cm2 (thus with a
reaction yield equal to 1% with respect to the anchored peptide
surface density).
Addition of MMP-2 to the functionalized chip surface pro-
duces a transient, slight increase of RU that is possibly due to the
association of the enzyme to the substrate. Relevant to this point,
Figure 1. Schematic representation of the bifunctional peptide linker containing the MMP-2-cleavage site of CCL12.
Figure 2. Schematic representation of the strategy for site-speciﬁc immobilization of proteins via a cleavable peptide linker here adopted. Boc = tert-
butyloxycarbonyl.
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the interaction of MMP-2 to CCL12 has been demonstrated to
be very strong.10 The slight increase of RU is, however, followed
by a rapid decrement that reaches the level of RUs present on the
sensorchip before BSA-Ketone injection.
To demonstrate the speciﬁcity of the protein association/
cleavage observed, we injected BSA-Ketone on a gold sensorchip
devoid of the peptide linker. In these experimental conditions, we
observed an increase of RU equal to about 800 RU (due to
unspeciﬁc adsorption of the protein to the gold surface11), but
the subsequent treatment with MMP-2 did not produce any
modiﬁcation, in agreement with the lack of cleavable linker (data
not shown). Relevant to this point, the observation that MMP2
completely removes peptide linker-associated BSA-Ketone sug-
gests that, in our experimental conditions, no unspeciﬁc absorp-
tion of BSA-Ketone to the gold surface occurs, possibly due to
the fact that the previous immobilization of the peptide linker has
saturated the unspeciﬁc binding sites available on the gold surface.
Finally, the reliability of the strategy proposed here is proven by
the reproducibility of the results obtained in four repeated
independent experiments (Figure 4).
In this paper, we have successfully designed and produced a
bifunctional cleavable peptide that is able to eﬃciently link a
protein to a gold surface through chemoselective immobilization
and that eﬀectively allows the controlled release of the protein
by administering the appropriate enzyme. These results open up
the possibility to immobilize to a surface enzymes, receptors, or
antibodies with a precise orientation, leaving bioactive sites free
for interaction with substrates, ligands, antigens, or drugs. This
may impact the ﬁeld of SPR analysis that, in the past years, has
emerged as a powerful asset in the study of biomolecular interac-
tions and drug development.12 Actually, the strategy adopted here
requires the exploitation of the N-terminus of the protein,
hampering the immobilization of receptors in the proper orien-
tation that would allow their interaction with extracellular
ligands. Relevant to this point, alternative strategies have been
individuated to overcome this limit: Carrico et al. have developed
methods for site-speciﬁc introduction of aldehyde groups into
recombinant proteins using the 6-amino-acid consensus se-
quence recognized by the formylglycine generating enzyme.13 On
the other hand, the N-terminal immobilization of the cytoplasmic
tail of a receptors may be functional to the study of receptor
interaction with intracellular second messengers or intracellular
binders/inhibitors. Relevant to this point, tyrosine-kinase (TK)
receptors play pivotal roles in important human diseases such as
tumors14 and the development of small, cell-permeable drugs that
bind the intracellular portion of TK receptors (hampering their
activation and/or the docking of second messengers) represents a
promising therapeutical strategy.15 In this ﬁeld, the availability of a
fast, reliable method for N-terminal chemoselective immobilization
of TK receptors in SPR or other solid-phase assays would represent
a formidable opportunity, especially for high-throughput screening
of putative receptor binders/inhibitors.
Figure 3. BIAcore responses during the procedure of chemoselective immobilization of BSA to a gold sensorchip followed by the enzymatic cleavage of
the peptide linker. Boc = tert-butyloxycarbonyl.
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Another promising evolution path that originates from the
results presented here is the speciﬁc cleavage of a peptide linker
with the consequent controlled release of the associated com-
pound. Relevant to this point, the delivery and controlled release
of drugs from artiﬁcial particles is an expanding ﬁeld of research
with implications in the treatment of several important human
diseases including cancer.8,9 Interestingly, our peptide linker is
sensitive to MMP2. MMP2 is a zinc-dependent endopeptidase
overexpressed in advanced stages of cancer where it plays a
crucial role in tumor progression, angiogenesis, and metastasis.16
It is thus possible to hypothesize that an anticancer drug immobi-
lized to a particle via our peptide linker may be spontaneously
and speciﬁcally released in MMP2-containing lesions. Also, our
MMP2-labile peptide linker may behave in a “bioresponsive
way”, tuning drug release on the concentration of the metallo-
protease that, in turn, is proportional to the extension/severity of
the cancer lesion.16
Besides the approach reported here, a large number of advanced
synthetic techniques have recently become available to achieve
protein immobilization and modiﬁcation with positional control.
For example, the direct incorporation of noncanonical amino acids
into proteins can be carried out via the subversion of the biosyn-
theticmachinery:17 the subsequent coupling of synthetic molecules
to artiﬁcial amino acid side chains can yield novel bioconjugates. In
an alternative approach, that mimics post-translational modiﬁca-
tions, synthetic transformations can convert speciﬁc amino acid
residues on expressed natural protein into other native or modiﬁed
native groups.18When there is the necessity of protein labeling in a
highly complex environment, new enzymatic strategies, able to
append chemical functional groups to speciﬁc sequences, can be
used.19 In addition, antibodies represent another important class of
bioconjugation targets: novel methods for the selective modiﬁca-
tion of antibodies are presented in the review of Meares et al.20
In conclusion, in this paper we have designed and produced a
peptide linker able to (i) anchor a given protein to a surface in a
precise orientation and (ii) release the immobilized protein after
selective enzymatic cleavage. As it is, our peptide linker can be
considered both an improvement of SPR analysis for macro-
molecular interaction and a novel strategy for drug delivery and
biomaterial developments.
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